larsen0113

5. Opioidy 113

Baker KZ, Ostapkovich N, Sisti MB, Warner DS, Young WL: Intact cerebral blood flow reactivity during remifentanil/nitrous oxide anesthesia. J Neurosurg Anesth 9:134— 140, I997.

Bennett JA, Abrams JT, van Riper DF, Horrow JC: Difficull or impossible ventilation after sufentanil-induced anesthesia is caused primarily by vocal cordclosure. Anesthesiology 87:1070-1074, 1997.

Collard E, Delire V, Mayne A et al: Propofol-alfenta-nil versus fentanyl-midazolam in coronary artery surgery'. J Cardiothorac Vasc Anesth 10:869-876, 1996.

Dershwitz M, Hoke JF, Rosow CE et al: Pharmacoki-netics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology 84:8112-8120, 1996.

Egan TD, Minto CF, Hermann DJ, Barr J, Muir KT, ShaferSL: Remifentanil versus alfentanil. Compa-rative pharmacokinetics and pharmacodynamics in healthy adult małe volunteers. Anesthesiology 84:821-833, 1996.

Enlund M, Kobosko P, Rhodin A: A cost-benefit eva-luation of using propofol and alfentanil for a short gynecological procedurę. Acta Anaesthesiol Scand 40:416-420, 1996.

Freye E: Opioide in der Medizin, 4. Auflage. Springer Berlin 1999.

Gepts E, Shafer SL, Camu F, Stanski DR: Linearity of pharmacokinetic and model estimation of sufentanil. Anesthesiology 83:1194-1204, 1995.

Herz A (ed.): Opioids I and II. Handbook of Experi-mental Pharmacology 104/1 and II. Springer, Berlin 1993.

Hogue CW, Bowde TA, CTLeary C et al: A multicen-ter evaluation of total intravenous anesthesia with remifentanil and propofol for elective inpatient surgery. Anesth Analg 83:279-285, 1996.

Hoke J, Shlugman D, Dershwitz M et al: Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers. Anesthesiology 87:533-541, 1997.

Jhaveri R, Joshi P, Balenhorst R, Baughman V, Glass PSA: Dose comparison of remifentanil and alfentanil for loss of consciousness. Anesthesiology 87:253-259, 1997.

Kapila A, Glass PSA, Jacobs JR et al: Measured con-text-sensitive half-times of remifentanil and alfentanil. Anesthesiology 83:968-975, 1995.

Kazama T, Ikeda K, Morita K: Reduction by fentanyl of the Cp50 values of propofol and hemodynamic responses to various noxious stimuli. Anesthesiology 87:213-227, 1997.

Lang E, Kapila A, Shlugman D et al: Reduction of isoflurane minima! alveolar coneentration by remifentanil. Anesthesiology 85:21-28, 1996.

Larsen B, Seitz. A, Larsen R: Recovery of cognitive function after remifentanil-propofol anesthesia: a comparison with desflurane and sevoflurane anesthesia. Anesth Analg 90:168-74, 2000.

Michelsen LG, Salmenpera M. Hug CG, Szlam F. Van der Meer D: Anesthetic potency of remifentanil in dogs. Anesthesiology 84:865-872, 1996.

Minto CF, Schnider TW, Egan TD et al: Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. Anesthesiology 86:10-23, 1997.

Scorbara C, Pittarello D, Rizzoli G et al: Propofol-fentanyl versus isoflurane-fentany! anesthesia for coronary artery bypass grafting: effect on myocar-dial contractility and peripheral hemodynamics. J Cardiothorac Vasc Anesth 9:18-23, 1995.

Shafer SL: New Intravenous Anesthetic - Remifentanil, Refresher Courses in Anesthesiology. The American Society of Anesthesiologists, Vol. 24, pp. 242-255. Lippincott-Raven, Philadelphia 1996.

Stein A, Helmke K, Szopko C, Stein C, Yassouridis A: Intraartikuliire Mophin- versus Steroidapplica-tion bei Gonarthrose und Arthritis im akut schme-rzhaften Gelenk. Dtsch Med Wochenschr 8:255, 1996.

Stein C, Schafer M. Hassan AM: Peripheral opioid receptors. Ann Med 27:219-221, 1995.

Warner DS, Hindman BJ, Todd MM et al: Intracranial pressure and hemodynamic effects of remifentanil versus alfentanil in patients undergoing supratento-rial craniotomy. Anesth Analg 83:348-353, 1996.

Wilhelm W. Huppert A. Briin K, GriineB V, Larsen R: Remifentanil mit Propofol oder Isofluran. Ein Ver-gleich des Aufwachverhaltens bei arthroskopi-schen Eingriffen. Anaesthesist 46:335-338, 1997.